Open access peer-reviewed chapter

Epidemiology of Patients Diagnosed with Prescription and Non-Prescription Drug Overdose at the Riyadh Security Forces Hospital Between January 2007 and December 2011

By Naser Al-Jaser, M. Cli. Epi and Niyi Awofeso

Submitted: May 21st 2012Reviewed: August 30th 2012Published: May 15th 2013

DOI: 10.5772/52879

Downloaded: 785

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Naser Al-Jaser, M. Cli. Epi and Niyi Awofeso (May 15th 2013). Epidemiology of Patients Diagnosed with Prescription and Non-Prescription Drug Overdose at the Riyadh Security Forces Hospital Between January 2007 and December 2011, Current Topics in Public Health, Alfonso J. Rodriguez-Morales, IntechOpen, DOI: 10.5772/52879. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/current-topics-in-public-health/epidemiology-of-patients-diagnosed-with-prescription-and-non-prescription-drug-overdose-at-the-riyad" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

785total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Contribution of Biomedical Research Ethics in Public Health Advances

By C.N. Fokunang, EA Tembe-Fokunang, M. Djuidje Ngounoue, P.C. Chi, J Ateudjieu, Awah Pascal, G. Magne, N.M. Ndje, O.M.T. Abena, D. Sprumont and Kaptue Lazare

Related Book

First chapter

Rickettsiosis as Threat for the Traveller

By Aránzazu Portillo and José A. Oteo

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More about us